Developer docs
API playgroundTry for free, no card

Search company profiles

HC Solutions

Full company profile

uuid02ifegj

Namestring
HC Solutions
Legal namestring
Baltic HC Solutions OÜ
Websiteurl
hcsolutions.ee
Company typeenum
Private
Founded yearint
2012
Descriptiontext

HC Solutions (legally Baltic HC Solutions OÜ) is an Estonian healthcare consultancy founded in 2012 that helps pharmaceutical, biotech, and medical device companies secure market access and reimbursement across European markets. The firm operates from Viimsi Parish, Harju County, Estonia, with a multidisciplinary team of roughly 16 personnel — including medical professionals, IT specialists, bioresearchers, biostatisticians, and cost-effectiveness analysts, supplemented by external experts in biostatistics, mathematics, and data science.

The company's service portfolio spans five integrated lines: Market Access and HTA Consulting (HTA dossier preparation, reimbursement strategy, budget impact modelling, business opportunity assessment); Medical Writing and Literature Search (regulatory writing, systematic reviews, meta-analyses); Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, value-based healthcare assessment, personalised medicine including AI-driven risk prediction and genomics/biomarker analysis); Medical Device / SaMD services (HTA, pricing, early evidence planning); and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP procedures, labelling, Local Responsible Person for Pharmacovigilance). A proprietary asset is the first pan-European healthcare model developed in 2020, and 2024 research extends predictive modelling into macroeconomic healthcare impact assessment.

HC Solutions generates revenue through project-based consulting engagements and multi-year contracts with enterprise pharmaceutical, biotech, and medical device clients, as well as medical device startups. Pricing is custom-quoted with no public rate card, and go-to-market is consultative B2B sales delivered via direct engagement, the company website, and industry events — with no reseller or partner channel. The company claims 100+ successful reimbursement projects delivered since 2012, and serves clients globally with a European concentration, led by the Baltic region.

Short descriptiontext

HC Solutions is an Estonian healthcare consultancy founded in 2012 that provides market access, HTA, predictive modelling, medical writing, medical device, and regulatory affairs services to pharmaceutical, biotech, and medical device companies across European markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTallinn, Estonia
HQ citystring
Tallinn
HQ countrystring
Estonia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare market access, HTA consulting services, predictive healthcare modelling, medical device reimbursement, regulatory affairs consulting
Industry2 codes
PRIMARYHLAJACAF
Health Technology Assessment (HTA) & Reimbursement Policy Bodies
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLACAHAJ
Cost of Care, Spend Analytics & Financial Performance Management
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code1 code
  • Management Consulting Services54161
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Health Services8000
Product category
Healthcare Market Access Consulting
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Consultancy Services
TypeProfessional Services
Description

B2B consulting services for pharmaceutical and medical device companies including market access strategy, HTA consulting, regulatory affairs, pharmacovigilance, medical writing, and predictive modelling. Revenue generated through project-based engagements and ongoing consulting retainer arrangements.

hcsolutions.ee
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Custom project-based consulting
ModelOtherBilling cadenceMulti-year contract
Notes

Services are tailored to individual client requirements and project scope. Pricing determined through direct consultation. No tiered pricing or standard rate cards publicly available.

hcsolutions.ee
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HC Solutions is a healthcare consultancy delivering market access services, Health Technology Assessment (HTA) consulting, predictive modelling, medical writing, medical device reimbursement support, and regulatory affairs and pharmacovigilance services for pharmaceutical, biotech, and medical device companies across Europe. The firm helps healthcare innovators prepare HTA dossiers, develop reimbursement strategies, demonstrate cost-effectiveness through patient-based modelling, and navigate regulatory pathways in the Baltic region and broader European markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 100+ successful reimbursement projects delivered since 2012
+1 more record
Product overview1 text field

HC Solutions is a healthcare consultancy company offering a unified portfolio of consulting services rather than a software product platform. The core offering centers on Market Access Services (including HTA consulting, reimbursement strategy, and dossier preparation) and Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, and personalized medicine). Supporting these are specialized services including Medical Writing and Literature Search Services (regulatory writing, systematic reviews, meta-analyses), Medical Device/Software as Medical Device Services (HTA strategy, pricing, early evidence planning), and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP assistance, labelling, pharmacovigilance). The services are delivered by a multidisciplinary team and are designed to work together holistically—e.g., predictive modelling supports the market access and pricing strategies, while regulatory affairs and medical writing provide evidence to underpin HTA dossiers.

Product and service5 records
1Market Access and HTA Consulting Services
CategoryMarket Access and HTA Consulting
Description

Comprehensive consulting to help bring healthcare innovations to market, including crafting robust HTA dossiers, shaping long-term reimbursement strategies, cost-effectiveness analyses, budget impact modelling, business opportunity assessment, sustainable pricing strategies, and patient access schemes for pharmaceutical, biotech, and medical device clients.

2Medical Writing and Literature Search Services
CategoryMedical Writing and Evidence Synthesis
Description

Delivery of precise, well-structured medical content including regulatory writing, scientific publications, medical communications, systematic literature reviews, targeted literature searches, critical appraisal, meta-analyses, comparative effectiveness research, and real-world data analysis for healthcare professionals and regulatory submissions.

3Predictive Modelling in Healthcare
CategoryHealthcare Analytics and Predictive Modelling
Description

Data-driven predictive tools for healthcare decisions including patient-based cost-efficiency modelling, economic impact analyses (healthcare policy change, pandemic and public health crisis modelling, workforce productivity and GDP growth analysis), value-based healthcare assessment, personalized medicine analytics (genomics, biomarker analysis, AI-driven risk prediction), and employer workforce health studies.

4Medical Device / Software as Medical Device Services
CategoryMedical Device Market Access
Description

Support for medical device innovators with HTA and reimbursement strategies, cost modelling, pricing negotiations, early evidence planning for investigational studies, regulatory alignment, and crafting reimbursement roadmaps to secure funding and market approvals for both established medical device companies and startups.

5Regulatory Affairs and Pharmacovigilance
CategoryRegulatory Affairs and Pharmacovigilance
Description

Strategic and operational regulatory support across the Baltic region including pharmaceutical regulatory submissions, MRP/DCP (Mutual Recognition and Decentralised Procedures) assistance and local liaison, end-to-end Marketing Authorisation Application management, labelling and product information management (translations, packaging maintenance), and pharmacovigilance services including Local Responsible Person for Pharmacovigilance (LPPV), safety data collection, EU QPPV reporting, and local literature screening.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cogentia is a UK/European health economics and market access consultancy. Comparable boutique competitor delivering HTA submissions, health economic modelling, and pricing strategy to pharma and medical device companies.

TypeDirect peer
Description

Evidera (now part of Thermo Fisher/PPD) is a leading HEOR, market access, and HTA consulting firm serving pharma and biotech. Direct comparable — both deliver HTA dossier preparation, cost-effectiveness modelling, and value communication for the same pharmaceutical and medical device buyer base.

TypeBroad incumbent
Description

Parexel is a major global CRO with a market access and HEOR practice. Competes with HC Solutions on HTA submissions and pricing strategy for pharma clients, but operates at a much larger scale with broader clinical and regulatory services.

TypeBroad incumbent
Description

Syneos Health is a global biopharma solutions organization offering market access, HEOR, and HTA consulting alongside clinical and commercial services. Broader incumbent competing with HC Solutions for integrated pharma engagement opportunities.

TypeBroad incumbent
Description

CRA's Life Sciences practice provides HEOR, market access, and pricing strategy consulting to pharma and medical device clients. Established competitor in the same HTA/value demonstration space, though typically serves larger enterprise engagements.

6Analytica LASER
TypeDirect peer
Description

Analytica LASER is a Canadian/European HEOR and market access consultancy providing HTA submissions, cost-effectiveness modelling, and real-world evidence generation. Direct comparable for HC Solutions' predictive modelling and HTA service lines.

TypeDirect peer
Description

UK-based market access and HTA consultancy serving pharma and medical device clients across Europe. Comparable boutique peer with similar service portfolio including HTA submissions, systematic reviews, and payer engagement — competing for similar European mid-size pharma/medtech engagements.

TypeDirect peer
Description

Xcenda (part of Cencora/AmerisourceBergen) provides HEOR, market access, and HTA consulting to pharma and medtech manufacturers. Direct comparable in payer evidence generation, HTA dossiers, and value-based contracting support.

TypeBroad incumbent
Description

IQVIA is a global CRO and health data giant offering integrated market access, HEOR, and HTA consulting as part of broader clinical and commercial services. Competes with HC Solutions for pharma market access engagements but offers much wider portfolio including RWE, clinical, and commercial.

TypeDirect peer
Description

PHMR is a specialist market access and HEOR consultancy working with pharma, biotech, and medical device companies. Direct competitor in HTA dossier preparation, value demonstration, and pricing/reimbursement strategy across European markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HC Solutions

Healthcare Market Access Consultinghcsolutions.ee

HC Solutions is an Estonian healthcare consultancy founded in 2012 that provides market access, HTA, predictive modelling, medical writing, medical device, and regulatory affairs services to pharmaceutical, biotech, and medical device companies across European markets.

What HC Solutions does

HC Solutions (legally Baltic HC Solutions OÜ) is an Estonian healthcare consultancy founded in 2012 that helps pharmaceutical, biotech, and medical device companies secure market access and reimbursement across European markets. The firm operates from Viimsi Parish, Harju County, Estonia, with a multidisciplinary team of roughly 16 personnel — including medical professionals, IT specialists, bioresearchers, biostatisticians, and cost-effectiveness analysts, supplemented by external experts in biostatistics, mathematics, and data science.

The company's service portfolio spans five integrated lines: Market Access and HTA Consulting (HTA dossier preparation, reimbursement strategy, budget impact modelling, business opportunity assessment); Medical Writing and Literature Search (regulatory writing, systematic reviews, meta-analyses); Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, value-based healthcare assessment, personalised medicine including AI-driven risk prediction and genomics/biomarker analysis); Medical Device / SaMD services (HTA, pricing, early evidence planning); and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP procedures, labelling, Local Responsible Person for Pharmacovigilance). A proprietary asset is the first pan-European healthcare model developed in 2020, and 2024 research extends predictive modelling into macroeconomic healthcare impact assessment.

HC Solutions generates revenue through project-based consulting engagements and multi-year contracts with enterprise pharmaceutical, biotech, and medical device clients, as well as medical device startups. Pricing is custom-quoted with no public rate card, and go-to-market is consultative B2B sales delivered via direct engagement, the company website, and industry events — with no reseller or partner channel. The company claims 100+ successful reimbursement projects delivered since 2012, and serves clients globally with a European concentration, led by the Baltic region.

HC Solutions firmographics

Firmographics
Name
HC Solutions
Legal name
Baltic HC Solutions OÜ
Website
https://hcsolutions.ee
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
HC Solutions is an Estonian healthcare consultancy founded in 2012 that provides market access, HTA, predictive modelling, medical writing, medical device, and regulatory affairs services to pharmaceutical, biotech, and medical device companies across European markets.
Ownership category
akta.pro rank

HC Solutions industry classification

Industry
Product category
Healthcare Market Access Consulting
NAICS
Management Consulting Services (54161)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAJACAF
Health Technology Assessment (HTA) & Reimbursement Policy Bodies
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLACAHAJ
Cost of Care, Spend Analytics & Financial Performance Management
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Healthcare market access
  • HTA consulting services
  • Predictive healthcare modelling
  • Medical device reimbursement
  • Regulatory affairs consulting

Where HC Solutions is headquartered

Location

Headquarters

HQ city
Tallinn
HQ country
Estonia
HQ region
Europe

Offices1 record

Markets served

HC Solutions business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Healthcare Consultancy Services: B2B consulting services for pharmaceutical and medical device companies including market access strategy, HTA consulting, regulatory affairs, pharmacovigilance, medical writing, and predictive modelling. Revenue generated through project-based engagements and ongoing consulting retainer arrangements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based consulting

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

HC Solutions product offering

Product offering

Core offering

HC Solutions is a healthcare consultancy delivering market access services, Health Technology Assessment (HTA) consulting, predictive modelling, medical writing, medical device reimbursement support, and regulatory affairs and pharmacovigilance services for pharmaceutical, biotech, and medical device companies across Europe. The firm helps healthcare innovators prepare HTA dossiers, develop reimbursement strategies, demonstrate cost-effectiveness through patient-based modelling, and navigate regulatory pathways in the Baltic region and broader European markets.

Product overview

HC Solutions is a healthcare consultancy company offering a unified portfolio of consulting services rather than a software product platform. The core offering centers on Market Access Services (including HTA consulting, reimbursement strategy, and dossier preparation) and Predictive Modelling in Healthcare (patient-based cost-efficiency modelling, economic impact analyses, and personalized medicine). Supporting these are specialized services including Medical Writing and Literature Search Services (regulatory writing, systematic reviews, meta-analyses), Medical Device/Software as Medical Device Services (HTA strategy, pricing, early evidence planning), and Regulatory Affairs and Pharmacovigilance (regulatory submissions, MRP/DCP assistance, labelling, pharmacovigilance). The services are delivered by a multidisciplinary team and are designed to work together holistically—e.g., predictive modelling supports the market access and pricing strategies, while regulatory affairs and medical writing provide evidence to underpin HTA dossiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Market Access and HTA Consulting Services Comprehensive consulting to help bring healthcare innovations to market, including crafting robust HTA dossiers, shaping long-term reimbursement strategies, cost-effectiveness analyses, budget impact modelling, business opportunity assessment, sustainable pricing strategies, and patient access schemes for pharmaceutical, biotech, and medical device clients.
  • Medical Writing and Literature Search Services Delivery of precise, well-structured medical content including regulatory writing, scientific publications, medical communications, systematic literature reviews, targeted literature searches, critical appraisal, meta-analyses, comparative effectiveness research, and real-world data analysis for healthcare professionals and regulatory submissions.
  • Predictive Modelling in Healthcare Data-driven predictive tools for healthcare decisions including patient-based cost-efficiency modelling, economic impact analyses (healthcare policy change, pandemic and public health crisis modelling, workforce productivity and GDP growth analysis), value-based healthcare assessment, personalized medicine analytics (genomics, biomarker analysis, AI-driven risk prediction), and employer workforce health studies.
  • Medical Device / Software as Medical Device Services Support for medical device innovators with HTA and reimbursement strategies, cost modelling, pricing negotiations, early evidence planning for investigational studies, regulatory alignment, and crafting reimbursement roadmaps to secure funding and market approvals for both established medical device companies and startups.
  • Regulatory Affairs and Pharmacovigilance Strategic and operational regulatory support across the Baltic region including pharmaceutical regulatory submissions, MRP/DCP (Mutual Recognition and Decentralised Procedures) assistance and local liaison, end-to-end Marketing Authorisation Application management, labelling and product information management (translations, packaging maintenance), and pharmacovigilance services including Local Responsible Person for Pharmacovigilance (LPPV), safety data collection, EU QPPV reporting, and local literature screening.

Quantifiable outcome

  • 100+ successful reimbursement projects delivered since 2012
  • +1 more outcomes

Companies that use HC Solutions

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

HC Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

HC Solutions partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

HC Solutions competitors and assessment

Company assessment

Direct peers

  • Cogentia Healthcare Consulting: Cogentia is a UK/European health economics and market access consultancy. Comparable boutique competitor delivering HTA submissions, health economic modelling, and pricing strategy to pharma and medical device companies.
  • Evidera: Evidera (now part of Thermo Fisher/PPD) is a leading HEOR, market access, and HTA consulting firm serving pharma and biotech. Direct comparable — both deliver HTA dossier preparation, cost-effectiveness modelling, and value communication for the same pharmaceutical and medical device buyer base.
  • Analytica LASER: Analytica LASER is a Canadian/European HEOR and market access consultancy providing HTA submissions, cost-effectiveness modelling, and real-world evidence generation. Direct comparable for HC Solutions' predictive modelling and HTA service lines.
  • Mtech Access: UK-based market access and HTA consultancy serving pharma and medical device clients across Europe. Comparable boutique peer with similar service portfolio including HTA submissions, systematic reviews, and payer engagement — competing for similar European mid-size pharma/medtech engagements.
  • Xcenda: Xcenda (part of Cencora/AmerisourceBergen) provides HEOR, market access, and HTA consulting to pharma and medtech manufacturers. Direct comparable in payer evidence generation, HTA dossiers, and value-based contracting support.
  • PHMR (Portland Health and Marketing Research): PHMR is a specialist market access and HEOR consultancy working with pharma, biotech, and medical device companies. Direct competitor in HTA dossier preparation, value demonstration, and pricing/reimbursement strategy across European markets.

Broad incumbents

  • Parexel International: Parexel is a major global CRO with a market access and HEOR practice. Competes with HC Solutions on HTA submissions and pricing strategy for pharma clients, but operates at a much larger scale with broader clinical and regulatory services.
  • Syneos Health: Syneos Health is a global biopharma solutions organization offering market access, HEOR, and HTA consulting alongside clinical and commercial services. Broader incumbent competing with HC Solutions for integrated pharma engagement opportunities.
  • Charles River Associates (Life Sciences Practice): CRA's Life Sciences practice provides HEOR, market access, and pricing strategy consulting to pharma and medical device clients. Established competitor in the same HTA/value demonstration space, though typically serves larger enterprise engagements.
  • IQVIA: IQVIA is a global CRO and health data giant offering integrated market access, HEOR, and HTA consulting as part of broader clinical and commercial services. Competes with HC Solutions for pharma market access engagements but offers much wider portfolio including RWE, clinical, and commercial.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

HC Solutions social profiles

Digital presence

HC Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HC Solutions leadership team

Management profile

Number of profiles

Profiles16 records

HC Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HC Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HC Solutions

What does HC Solutions do?

HC Solutions is a healthcare consultancy delivering market access services, Health Technology Assessment (HTA) consulting, predictive modelling, medical writing, medical device reimbursement support, and regulatory affairs and pharmacovigilance services for pharmaceutical, biotech, and medical device companies across Europe. The firm helps healthcare innovators prepare HTA dossiers, develop reimbursement strategies, demonstrate cost-effectiveness through patient-based modelling, and navigate regulatory pathways in the Baltic region and broader European markets.

Is HC Solutions a public or private company?

HC Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was HC Solutions founded?

HC Solutions was founded in 2012. It employs 11 to 50 people.

Where is HC Solutions based?

HC Solutions is headquartered in Tallinn, Estonia, in the Europe region.

How does HC Solutions make money?

One revenue line is on record: healthcare Consultancy Services.

Who are HC Solutions's main competitors?

Direct peers on record are Cogentia Healthcare Consulting, Evidera, Analytica LASER, Mtech Access, Xcenda and PHMR (Portland Health and Marketing Research). Broad incumbents are Parexel International, Syneos Health, Charles River Associates (Life Sciences Practice) and IQVIA.

Does HC Solutions have an API?

No public API is recorded for HC Solutions.

What industry is HC Solutions in?

HC Solutions's product category is Healthcare Market Access Consulting. Its primary akta.pro industry code is HLAJACAF, Health Technology Assessment (HTA) & Reimbursement Policy Bodies, with a secondary code of HLACAHAJ, Cost of Care, Spend Analytics & Financial Performance Management. Its NAICS code is 54161 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales